Antibodies from S Africa COVID variant may offer cross-protection

Your video will begin in 5
Skip ad (0)

Members don't see these ads. Sign up or log in with Google or Twitter.
Published
South Africa has received its second batch of 80,000 vaccines donated by Johnson & Johnson.
But there are concerns the roll-out is going more slowly than expected while some critics have described it as a clinical trial.
Al Jazeera's Fahmida Miller reports from Johannesburg, South Africa.
-
-
-
-
#SouthAfrica #COVID19
Category
South Africa
Tags
johnson&johnson, safrica, southafrica, vaccine, covid-19
Be the first to comment